|
EP3643304A1
|
|
Pharmaceutical nanosuspension for the therapy of hiv infection
|
|
EP3473636A1
|
|
Nucleotides containing an n-[(s)-1-cyclobutoxycarbonyl]phosphoramidate fragment, analogs thereof, and use thereof
|
|
EP3400946A1
|
|
Antiviral composition and method for using same
|
|
US8889701B1
|
|
Substituted (S)-(2R,3R,5R)-3-hydroxy-(5-pyrimidin-1-yl)tetrahydrofuran-2-ylmethyl aryl phosphoramidate
|
|
WO2010129620A1
|
|
Imidazo [ 1, 2 -a] pyridin-2 -yl-phenyl derivatives to be used in cancer treatment
|
|
US2011245231A1
|
|
Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
|
|
KR20110069148A
|
|
Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof
|
|
EP2248817A2
|
|
Substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
|
|
WO2009082268A2
|
|
LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF
|
|
US2011039825A1
|
|
Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and their use
|
|
WO2007136302A2
|
|
Active substances, pharmaceutical composition and a method for the production and use thereof
|
|
WO2007136300A2
|
|
Substituted indoles and a method for the production and use thereof
|
